4//SEC Filing
Omrix Biopharmaceuticals, Inc. 4
Accession 0001209191-08-001649
CIK 0001349426operating
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 12:25 PM ET
Size
14.9 KB
Accession
0001209191-08-001649
Insider Transaction Report
Form 4
Burshtine Michael
Senior VP and CFO
Transactions
- Sale
Common Stock
2008-01-03$34.02/sh−4,546$154,655→ 0 total - Exercise/Conversion
Common Stock
2008-01-03$6.19/sh+6,335$39,214→ 6,335 total - Exercise/Conversion
Common Stock
2008-01-03$13.75/sh+4,546$62,508→ 4,546 total - Exercise/Conversion
Common Stock
2008-01-02$6.19/sh+70,091$433,863→ 70,091 total - Sale
Common Stock
2008-01-02$34.45/sh−70,091$2,414,635→ 0 total - Sale
Common Stock
2008-01-03$34.01/sh−6,335$215,453→ 0 total - Exercise/Conversion
Stock Option
2008-01-03−70,091→ 32,665 totalExercise: $6.19From: 2006-04-26Exp: 2015-01-13→ Common Stock (70,091 underlying)
Documents
Issuer
Omrix Biopharmaceuticals, Inc.
CIK 0001349426
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001349426
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 12:25 PM ET
- Size
- 14.9 KB